IBDEI0KQ ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,9665,0)
 ;;=92250^^43^490^6^^^^1
 ;;^UTILITY(U,$J,358.3,9665,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,9665,1,2,0)
 ;;=2^Fundus Photography
 ;;^UTILITY(U,$J,358.3,9665,1,3,0)
 ;;=3^92250
 ;;^UTILITY(U,$J,358.3,9666,0)
 ;;=66030^^43^491^5^^^^1
 ;;^UTILITY(U,$J,358.3,9666,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,9666,1,2,0)
 ;;=2^Inj Treatment of Eye,Medication
 ;;^UTILITY(U,$J,358.3,9666,1,3,0)
 ;;=3^66030
 ;;^UTILITY(U,$J,358.3,9667,0)
 ;;=67028^^43^491^6^^^^1
 ;;^UTILITY(U,$J,358.3,9667,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,9667,1,2,0)
 ;;=2^Intravitreal Inj of Eye Drug
 ;;^UTILITY(U,$J,358.3,9667,1,3,0)
 ;;=3^67028
 ;;^UTILITY(U,$J,358.3,9668,0)
 ;;=67500^^43^491^10^^^^1
 ;;^UTILITY(U,$J,358.3,9668,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,9668,1,2,0)
 ;;=2^Retrobulbar Inj,Medication
 ;;^UTILITY(U,$J,358.3,9668,1,3,0)
 ;;=3^67500
 ;;^UTILITY(U,$J,358.3,9669,0)
 ;;=67505^^43^491^9^^^^1
 ;;^UTILITY(U,$J,358.3,9669,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,9669,1,2,0)
 ;;=2^Retrobulbar Inj,Alcohol
 ;;^UTILITY(U,$J,358.3,9669,1,3,0)
 ;;=3^67505
 ;;^UTILITY(U,$J,358.3,9670,0)
 ;;=68200^^43^491^13^^^^1
 ;;^UTILITY(U,$J,358.3,9670,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,9670,1,2,0)
 ;;=2^Subconjunctival Injection
 ;;^UTILITY(U,$J,358.3,9670,1,3,0)
 ;;=3^68200
 ;;^UTILITY(U,$J,358.3,9671,0)
 ;;=96372^^43^491^11^^^^1
 ;;^UTILITY(U,$J,358.3,9671,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,9671,1,2,0)
 ;;=2^SC/IM Injection
 ;;^UTILITY(U,$J,358.3,9671,1,3,0)
 ;;=3^96372
 ;;^UTILITY(U,$J,358.3,9672,0)
 ;;=96402^^43^491^12^^^^1
 ;;^UTILITY(U,$J,358.3,9672,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,9672,1,2,0)
 ;;=2^SQ/IM Anti-Neplastic Hormone Inj
 ;;^UTILITY(U,$J,358.3,9672,1,3,0)
 ;;=3^96402
 ;;^UTILITY(U,$J,358.3,9673,0)
 ;;=C9257^^43^491^2^^^^1
 ;;^UTILITY(U,$J,358.3,9673,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,9673,1,2,0)
 ;;=2^Bevacizumab Inj 0.25mg
 ;;^UTILITY(U,$J,358.3,9673,1,3,0)
 ;;=3^C9257
 ;;^UTILITY(U,$J,358.3,9674,0)
 ;;=J1094^^43^491^4^^^^1
 ;;^UTILITY(U,$J,358.3,9674,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,9674,1,2,0)
 ;;=2^Dexamethasone Acetate Inj per 1mg
 ;;^UTILITY(U,$J,358.3,9674,1,3,0)
 ;;=3^J1094
 ;;^UTILITY(U,$J,358.3,9675,0)
 ;;=J2778^^43^491^8^^^^1
 ;;^UTILITY(U,$J,358.3,9675,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,9675,1,2,0)
 ;;=2^Ranibizumab Inj per 0.1mg
 ;;^UTILITY(U,$J,358.3,9675,1,3,0)
 ;;=3^J2778
 ;;^UTILITY(U,$J,358.3,9676,0)
 ;;=J3300^^43^491^14^^^^1
 ;;^UTILITY(U,$J,358.3,9676,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,9676,1,2,0)
 ;;=2^Triescence Inj per 1mg
 ;;^UTILITY(U,$J,358.3,9676,1,3,0)
 ;;=3^J3300
 ;;^UTILITY(U,$J,358.3,9677,0)
 ;;=J3301^^43^491^7^^^^1
 ;;^UTILITY(U,$J,358.3,9677,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,9677,1,2,0)
 ;;=2^Kenalog Inj per 10mg
 ;;^UTILITY(U,$J,358.3,9677,1,3,0)
 ;;=3^J3301
 ;;^UTILITY(U,$J,358.3,9678,0)
 ;;=J3396^^43^491^15^^^^1
 ;;^UTILITY(U,$J,358.3,9678,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,9678,1,2,0)
 ;;=2^Verteporfin Inj per 0.1mg
 ;;^UTILITY(U,$J,358.3,9678,1,3,0)
 ;;=3^J3396
 ;;^UTILITY(U,$J,358.3,9679,0)
 ;;=J9035^^43^491^3^^^^1
 ;;^UTILITY(U,$J,358.3,9679,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,9679,1,2,0)
 ;;=2^Bevacizumab Inj 10mg
 ;;^UTILITY(U,$J,358.3,9679,1,3,0)
 ;;=3^J9035
 ;;^UTILITY(U,$J,358.3,9680,0)
 ;;=J0178^^43^491^1^^^^1
 ;;^UTILITY(U,$J,358.3,9680,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,9680,1,2,0)
 ;;=2^Aflibercept Inj 1mg
 ;;^UTILITY(U,$J,358.3,9680,1,3,0)
 ;;=3^J0178
 ;;^UTILITY(U,$J,358.3,9681,0)
 ;;=67028^^43^492^5^^^^1
